Skip to content
Search

Latest Stories

One AZ Covid-19 vaccine dose gives 80pc lower death risk - English data

Data from the rollout of AstraZeneca's Covid-19 vaccine shows one dose of the shot results in 80 per cent less risk of death from the disease, Public Health England said on Monday (May 10).

It also said protection against death from the Pfizer-BioNTech vaccine rises from approximately 80 per cent after one dose to 97 per cent after two doses in its new analysis.


PHE said the study was the first on protection against mortality from the AstraZeneca vaccine based on data from a real world setting.

The study looked at new symptomatic cases of Covid-19 between December and April and people who died within 28 days of their positive test by vaccination status.

People who had a single dose of AstraZeneca vaccine were 55 per cent protected against death, with a figure of 44 per cent protection for a single dose of Pfizer, compared to unvaccinated people.

"Combined with the protection vaccines offer against becoming a case in the first place, this is equivalent to approximately 80 per cent protection against mortality in individuals vaccinated with a single dose of either vaccine," PHE said in a statement.

Protection against mortality from the Pfizer-BioNTech vaccine improved to 69 per cent for cases who had their second dose at least a week before they tested positive. Combined with the estimated protection from getting Covid-19 to start with, this is equivalent to an estimated 97 per cent protection, PHE said.

Prime minister Boris Johnson is set to confirm further easing of lockdown restrictions in England on Monday, helped in part by the speed of the country's vaccine rollout.

In another dataset, PHE said that it was estimated that two doses of the Pfizer-BioNTech vaccine reduces the risk of hospitalisation by 93 per cent for the over 80s.

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less